Sector consensus Actuate Therapeutics, Inc.
Stocks
ACTU
US0050831009
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.9812 USD | -1.41% |
|
-8.30% | -83.97% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.68 | +1,090.72% | 3 | ||||||
| 187.07 | +16.92% | 18 | ||||||
| 1,178.3 | +17.91% | 15 | ||||||
| 49.74 | +15.47% | 24 | ||||||
| 199.55 | +66.29% | 22 | ||||||
| 102.91 | +23.62% | 20 | ||||||
| 2,453.79 | +8.57% | 15 | ||||||
| 1,397.26 | +18.41% | 8 | ||||||
| 53.69 | -8.01% | 16 | ||||||
| 21.57 | +62.99% | 13 | ||||||
| 619.67 | +34.24% | 19 | ||||||
| 678.06 | +27.57% | 16 | ||||||
| 133.55 | +72.62% | 21 | ||||||
| 109.9 | +59.78% | 20 | ||||||
| 110 | +65.46% | 12 | ||||||
| 12.75 | +50.35% | 4 | ||||||
| 109 | +87.51% | 9 | ||||||
| 100.16 | +56.66% | 16 | ||||||
| 120.08 | +33.05% | 13 | ||||||
| 228.89 | +33.88% | 9 | ||||||
| Average | 393.88 | +91.70% | 15 | ||||||
| Weighted average by Cap. | 523.15 | +30.27% | 17 |
- Stock Market
- Stocks
- ACTU Stock
- Sector Actuate Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
